Jonathan S. Leff M.B.A
|Age||Total Calculated Compensation||This person is connected to 177 board members in 10 different organizations across 21 different industries.|
See Board Relationships
Mr. Jonathan S. Leff, M.B.A., serves as Head of Clinical Development for Inflammation Disease Biology at Roche Palo Alto, LLC. Mr. Leff is a Partner of Deerfield Management Company, L.P. He is a Partner on the Private Transactions team and Chairman of the Deerfield Institute. He joined Deerfield in 2013 and focuses on venture capital and structured investments in biotechnology and pharmaceuticals. He served as General Partner of Warburg, Pincus & Co., since January 2000. ...
450 Lexington AvenuePhone: 212-878-0600
New York, New York 10017
Board Members Memberships*
Director and Chairman of Nominating & Corporate Governance Committee
Stanford Graduate School of Business
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.